Skip to main content
SpringerLink
Log in

The Effect of Systemic Chemotherapy on Neurogenesis, Plasticity and Memory

  • Chapter
  • First Online:
Neurogenesis and Neural Plasticity

Part of the book series: Current Topics in Behavioral Neurosciences ((CTBN,volume 15))

Abstract

Chemotherapy has been enormously successful in treating many forms of cancer and improving patient survival rates. With the increasing numbers of survivors, a number of cognitive side effects have become apparent. These have been called “chemobrain” or “chemofog” among patient groups, who describe the symptoms as a decline in memory, concentration and executive functions. Changes which, although subtle, can cause significant distress among patients and prevent a return to the quality of life experienced before treatment. This cognitive side effect of chemotherapy was not anticipated as it had been assumed that chemotherapy agents, administered systematically, could not cross the blood–brain barrier and that the brain was therefore protected from their action. It is now realised that low concentrations of many chemotherapy agents cross the blood–brain barrier and even those that are completely prevented from doing so, can induce the production of inflammatory cytokines in peripheral tissues which in turn can cross the blood–brain barrier and impact on the brain. A large number of patient studies have shown that cognitive decline is found in a proportion of patients treated with a variety of chemotherapy agents for different types of cancer. The deficits experienced by these patients can last for up to several years and have a deleterious effect on educational attainment and ability to return to work. Imaging studies of patients after systemic chemotherapy show that this treatment produces structural and functional changes in the brain some of which seem to persist even when the cognitive deficits have ceased. This suggests that, with time, brain plasticity may be able to compensate for the deleterious effects of chemotherapy treatment. A number of mechanisms have been suggested for the changes in brain structure and function found after chemotherapy. These include both central and peripheral inflammatory changes, demyelination of white matter tracts, a reduction in stem cell proliferation in both the hippocampal neurogenic region and by oligodendrocyte precursors as well as changes in hormonal or growth factor levels. A number of possible treatments have been suggested which range from pharmacological interventions to cognitive behavioural therapies. Some of these have only been tested in animal models while others have produced varying degrees of improvement in patient populations. Currently, there is no recognised treatment and a greater understanding of the causes of the cognitive decline experienced after chemotherapy will be key to finding ways of preventing or treating the effects of chemobrain.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abraham J, Haut MW, Moran MT, Filburn S, Lemiuex S, Kuwabara H (2008) Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging. Clin Breast Cancer 8:88–91

    PubMed  Google Scholar 

  • Adamcio B, Sargin D, Stradomska A, Medrihan L, Gertler C, Theis F, Zhang M, Muller M, Hassouna I, Hannke K et al (2008) Erythropoietin enhances hippocampal long-term potentiation and memory. BMC Biol 6:37

    PubMed  Google Scholar 

  • Agrawal K, Onami S, Mortimer JE, Pal SK (2010) Cognitive changes associated with endocrine therapy for breast cancer. Maturitas 67:209–214

    PubMed  CAS  Google Scholar 

  • Ahles TA (2012) Brain vulnerability to chemotherapy toxicities. Psychooncology 21:1141–1148

    Google Scholar 

  • Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7:192–201

    PubMed  CAS  Google Scholar 

  • Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, Whedon MB, Bivens S, Mitchell T, Greenberg ER et al (2002) Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20:485–493

    PubMed  CAS  Google Scholar 

  • Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Titus-Ernstoff L, Skalla K, Bakitas M, Silberfarb PM (2005) Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy. J Clin Oncol 23:4399–4405

    PubMed  CAS  Google Scholar 

  • Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, Hanscom BS, Mulrooney TJ, Schwartz GN, Kaufman PA (2010) Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 28:4434–4440

    PubMed  Google Scholar 

  • Ahles TA, Saykin AJ, Noll WW, Furstenberg CT, Guerin S, Cole B, Mott LA (2003) The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology 12:612–619

    PubMed  Google Scholar 

  • Akatsu Y, Saikawa Y, Kubota T, Akatsu T, Yoshida M, Kitagawa Y, Otani Y, Kumai K, Kitajima M (2007) Predictive value of GADD153, p21 and c-Jun for chemotherapy response in gastric cancer. Cancer Sci 98:707–715

    PubMed  CAS  Google Scholar 

  • Akitake R, Miyamoto S, Nakamura F, Horimatsu T, Ezoe Y, Muto M, Chiba T (2011) Early detection of 5-FU-induced acute leukoencephalopathy on diffusion-weighted MRI. Jpn J Clin Oncol 41:121–124

    PubMed  Google Scholar 

  • Aluise CD, Sultana R, Tangpong J, Vore M, St Clair D, Moscow JA, Butterfield DA (2010). Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction. Adv Exp Med Biol 678:147–156

    Google Scholar 

  • Baj G, D’Alessandro V, Musazzi L, Mallei A, Sartori CR, Sciancalepore M, Tardito D, Langone F, Popoli M, Tongiorgi E (2012) Physical exercise and antidepressants enhance BDNF targeting in hippocampal CA3 dendrites: further evidence of a spatial code for BDNF splice variants. Neuropsychopharmacology 37:1600–1611

    PubMed  CAS  Google Scholar 

  • Bastos GN, Moriya T, Inui F, Katura T, Nakahata N (2008) Involvement of cyclooxygenase-2 in lipopolysaccharide-induced impairment of the newborn cell survival in the adult mouse dentate gyrus. Neuroscience 155:454–462

    PubMed  CAS  Google Scholar 

  • Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C, Armulik A, Sallstrom J et al (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485:512–516

    PubMed  CAS  Google Scholar 

  • Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, Ryan CM (2006) Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 15:422–430

    PubMed  Google Scholar 

  • Bender CM, Sereika SM, Brufsky AM, Ryan CM, Vogel VG, Rastogi P, Cohen SM, Casillo FE, Berga SL (2007) Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause 14:995–998

    PubMed  Google Scholar 

  • Bidwell LC, McClernon FJ, Kollins SH (2011) Cognitive enhancers for the treatment of ADHD. Pharmacol Biochem Behav 99:262–274

    PubMed  CAS  Google Scholar 

  • Biegler KA, Chaoul MA, Cohen L (2009) Cancer, cognitive impairment, and meditation. Acta Oncol 48:18–26

    PubMed  Google Scholar 

  • Biglia N, Bounous VE, Malabaila A, Palmisano D, Torta DM, D’Alonzo M, Sismondi P, Torta R (2012) Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study. Eur J Cancer Care (Engl) 21:485–492

    CAS  Google Scholar 

  • Blaney SM, Berg SL, Boddy AV (2004) Drug delivery. In: Walker DA, Perilongo G, Punt G, Taylor RE (eds) Brain and spinal tumours of childhood. Hodder Arnold, London

    Google Scholar 

  • Boldrini M, Underwood MD, Hen R, Rosoklija, GB, Dwork AJ, John Mann J, Arango V (2009). Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 34:2376–2389

    Google Scholar 

  • Bourke RS, West CR, Chheda G, Tower DB (1973) Kinetics of entry and distribution of 5-fluorouracil in cerebrospinal fluid and brain following intravenous injection in a primate. Cancer Res 33:1735–1746

    PubMed  CAS  Google Scholar 

  • Boykoff N, Moieni M, Subramanian SK (2009) Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. J Cancer Surviv 3:223–232

    PubMed  Google Scholar 

  • Brann DW, Dhandapani K, Wakade C, Mahesh VB, Khan MM (2007) Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids 72:381–405

    PubMed  CAS  Google Scholar 

  • Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF (2000) Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18:2695–2701

    PubMed  CAS  Google Scholar 

  • Briones TL, Woods J (2011) Chemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications. BMC Neurosci 12:124

    PubMed  CAS  Google Scholar 

  • Bruno J, Hosseini SM, Kesler S (2012) Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors. Neurobiol Dis 48:329–338

    PubMed  Google Scholar 

  • Campisi J, d’Adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8:729–740

    PubMed  CAS  Google Scholar 

  • Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA (2004) Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26:955–969

    PubMed  Google Scholar 

  • Castren E, Rantamaki T (2010) The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev Neurobiol 70:289–297

    PubMed  CAS  Google Scholar 

  • Chang J, Couture FA, Young SD, Lau CY, Lee McWatters K (2004). Weekly administration of epoetin alfa improves cognition and quality of life in patients with breast cancer receiving chemotherapy. Support Cancer Ther 2:52–58

    Google Scholar 

  • Cho YK, Kim G, Park S, Sim JH, Won YJ, Hwang CH, Yoo JY, Hong HN (2012) Erythropoietin promotes oligodendrogenesis and myelin repair following lysolecithin-induced injury in spinal cord slice culture. Biochem Biophys Res Commun 417:753–759

    PubMed  CAS  Google Scholar 

  • Christie LA, Acharya MM, Parihar VK, Nguyen A, Martirosian, V, Limoli CL (2012) Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy. Clin Cancer Res 18:1954–1965

    Google Scholar 

  • Cimprich B, Reuter-Lorenz P, Nelson J, Clark PM, Therrien B, Normolle D, Berman MG, Hayes DF, Noll DC, Peltier S et al (2010) Prechemotherapy alterations in brain function in women with breast cancer. J Clin Exp Neuropsychol 32:324–331

    PubMed  Google Scholar 

  • Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S (2009) Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psychooncology 18:134–143

    PubMed  Google Scholar 

  • Correa DD, Hess LM (2012) Cognitive function and quality of life in ovarian cancer. Gynecol Oncol 124:404–409

    PubMed  Google Scholar 

  • Cotman CW, Berchtold NC, Christie LA (2007) Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci 30:464–472

    PubMed  CAS  Google Scholar 

  • Cueva JF, Calvo M, Anido U, Leon L, Gallardo E, Areses C, Bernardez B, Gayoso L, Garcia J, Jesus Lamas M et al (2012). Methylphenidate in the management of asthenia in breast cancer patients treated with docetaxel: results of a pilot study. Invest New Drugs 30:688–694

    Google Scholar 

  • Dabrowska M, Mosieniak G, Skierski J, Sikora E, Rode W (2009) Methotrexate-induced senescence in human adenocarcinoma cells is accompanied by induction of p21(waf1/cip1) expression and lack of polyploidy. Cancer Lett 284:95–101

    PubMed  CAS  Google Scholar 

  • Dabrowska M, Skoneczny M, Rode W (2011) Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells. Tumour Biol 32:965–976

    PubMed  CAS  Google Scholar 

  • de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, Lavini C, Linn SC, Boven E, van Dam FS et al (2011a) Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging. Hum Brain Mapp 33:2971–2983

    Google Scholar 

  • de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, van Dam FS, Nederveen AJ, Boven E, Schagen SB (2011b) Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp 32:1206–1219

    PubMed  Google Scholar 

  • De Waele S, Van Belle S (2010) Cancer-related fatigue. Acta Clin Belg 65:378–385

    PubMed  Google Scholar 

  • Debess J, Riis JO, Engebjerg MC, Ewertz M (2010) Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study. Breast Cancer Res Treat 121:91–100

    PubMed  CAS  Google Scholar 

  • Deng W, Aimone JB, Gage FH (2010) New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci 11:339–350

    PubMed  CAS  Google Scholar 

  • Deprez S, Amant F, Smeets A, Peeters R, Leemans A, Van Hecke W, Verhoeven JS, Christiaens MR, Vandenberghe J, Vandenbulcke M et al (2012) Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol 30:274–281

    PubMed  Google Scholar 

  • Deprez S, Amant F, Yigit R, Porke K, Verhoeven J, Van den Stock J, Smeets A, Christiaens MR, Leemans A, Van Hecke W et al (2011) Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp 32:480–493

    PubMed  Google Scholar 

  • Dietrich J, Han R, Yang Y, Mayer-Proschel M, Noble M (2006) CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol 5:22

    PubMed  Google Scholar 

  • Donovan KA, Small BJ, Andrykowski MA, Schmitt FA, Munster P, Jacobsen PB (2005) Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer 104:2499–2507

    PubMed  Google Scholar 

  • Ekdahl CT, Kokaia Z, Lindvall O (2009) Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 158:1021–1029

    PubMed  CAS  Google Scholar 

  • ElBeltagy M, Mustafa S, Umka J, Lyons L, Salman A, Chur-yoe GT, Bhalla N, Bennett G, Wigmore PM (2010) Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil. Behav Brain Res 208:112–117

    PubMed  CAS  Google Scholar 

  • ElBeltagy M, Mustafa S, Umka J, Lyons L, Salman A, Dormon K, Allcock C, Bennett G, Wigmore P (2012) The effect of 5-fluorouracil on the long term survival and proliferation of cells in the rat hippocampus. Brain Res Bull 88:514–518

    PubMed  CAS  Google Scholar 

  • Elsea CR, Roberts DA, Druker BJ, Wood LJ (2008) Inhibition of p38 MAPK suppresses inflammatory cytokine induction by etoposide, 5-fluorouracil, and doxorubicin without affecting tumoricidal activity. PLoS One 3:e2355

    PubMed  Google Scholar 

  • Encinas JM, Vaahtokari A, Enikolopov G (2006) Fluoxetine targets early progenitor cells in the adult brain. Proc Natl Acad Sci USA 103:8233–8238

    PubMed  CAS  Google Scholar 

  • Fan HG, Park A, Xu W, Yi QL, Braganza S, Chang J, Couture F, Tannock IF (2009) The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer. Psychooncology 18:156–161

    PubMed  Google Scholar 

  • Fardell JE, Vardy J, Johnston IN, Winocur G (2011) Chemotherapy and cognitive impairment: treatment options. Clin Pharmacol Ther 90:366–376

    PubMed  CAS  Google Scholar 

  • Fardell JE, Vardy J, Logge W, Johnston I (2010) Single high dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratory rodents. Pharmacol Biochem Behav 97:333–339

    PubMed  CAS  Google Scholar 

  • Fardell JE, Vardy J, Shah JD, Johnston IN (2012) Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity. Psychopharmacology (Berl) 220:183–193

    CAS  Google Scholar 

  • Ferguson RJ, McDonald BC, Rocque MA, Furstenberg CT, Horrigan S, Ahles TA, Saykin AJ (2012) Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial. Psychooncology 21:176–186

    PubMed  Google Scholar 

  • Ferguson RJ, McDonald BC, Saykin AJ, Ahles TA (2007) Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J Clin Oncol 25:3866–3870

    PubMed  Google Scholar 

  • Fremouw T, Fessler CL, Ferguson RJ, Burguete Y (2012a) Preserved learning and memory in mice following chemotherapy: 5-Fluorouracil and doxorubicin single agent treatment, doxorubicin-cyclophosphamide combination treatment. Behav Brain Res 226:154–162

    PubMed  CAS  Google Scholar 

  • Fremouw T, Fessler CL, Ferguson RJ, Burguete Y (2012b) Recent and remote spatial memory in mice treated with cytosine arabinoside. Pharmacol Biochem Behav 100:451–457

    PubMed  CAS  Google Scholar 

  • Gagnon B, Low G, Schreier G (2005) Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study. J Psychiatry Neurosci 30:100–107

    PubMed  Google Scholar 

  • Galalae RM, Michel J, Siebmann JU, Kuchler T, Eilf K, Kimmig B (2005) Significant negative impact of adjuvant chemotherapy on health-related quality of life (HR-QoL) in women with breast cancer treated by conserving surgery and postoperative 3-D radiotherapy. A prospective measurement. Strahlenther Onkol 181:645–651

    PubMed  Google Scholar 

  • Galica J, Rajacich D, Kane D, Pond GR (2012) The impact of chemotherapy-induced cognitive impairment on the psychosocial adjustment of patients with nonmetastatic colorectal cancer. Clin J Oncol Nurs 16:163–169

    PubMed  Google Scholar 

  • Gallassi R, Di Sarro R, Morreale A, Amore M (2006) Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy. J Affect Disord 91:243–250

    PubMed  CAS  Google Scholar 

  • Gandal MJ, Ehrlichman RS, Rudnick ND, Siegel SJ (2008) A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice. Neuroscience 157:95–104

    PubMed  CAS  Google Scholar 

  • Garthe A, Behr J, Kempermann G (2009) Adult-generated hippocampal neurons allow the flexible use of spatially precise learning strategies. PLoS One 4:e5464

    PubMed  Google Scholar 

  • Gewirtz DA, Holt SE, Elmore LW (2008) Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol 76:947–957

    PubMed  CAS  Google Scholar 

  • Goldman SA, Chen Z (2011) Perivascular instruction of cell genesis and fate in the adult brain. Nat Neurosci 14:1382–1389

    PubMed  CAS  Google Scholar 

  • Gottschalk LA, Holcombe RF, Jackson D, Bechtel RJ (2003) The effects of anticancer chemotherapeutic drugs on cognitive function and other neuropsychiatric dimensions in breast cancer patients. Methods Find Exp Clin Pharmacol 25:117–122

    PubMed  CAS  Google Scholar 

  • Han R, Yang YM, Dietrich J, Luebke A, Mayer-Proschel M, Noble M (2008) Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol 7:12

    PubMed  Google Scholar 

  • Hardwicke S (2009) Chemo brain and recovery. A guide for survival. eBook Vabion LLC

    Google Scholar 

  • Hedayati E, Alinaghizadeh H, Schedin A, Nyman H, Albertsson M (2012) Effects of adjuvant treatment on cognitive function in women with early breast cancer. Eur J Oncol Nurs 16:315–322

    PubMed  Google Scholar 

  • Hein AM, O’Banion MK (2009) Neuroinflammation and memory: the role of prostaglandins. Mol Neurobiol 40:15–32

    PubMed  CAS  Google Scholar 

  • Hermelink K, Henschel V, Untch M, Bauerfeind I, Lux MP, Munzel K (2008) Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study. Cancer 113:2431–2439

    PubMed  Google Scholar 

  • Hermelink K, Kuchenhoff H, Untch M, Bauerfeind I, Lux MP, Buhner M, Manitz J, Fensterer V, Munzel K (2010) Two different sides of ‘chemobrain’: determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study. Psychooncology 19:1321–1328

    PubMed  Google Scholar 

  • Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, Munzel K (2007) Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 109:1905–1913

    PubMed  CAS  Google Scholar 

  • Hernandez CM, Gearhart DA, Parikh V, Hohnadel EJ, Davis LW, Middlemore ML, Warsi SP, Waller JL, Terry AV Jr (2006) Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats. J Pharmacol Exp Ther 316:679–694

    Google Scholar 

  • Herrmann N, Chau SA, Kircanski I, Lanctot KL (2011) Current and emerging drug treatment options for Alzheimer’s disease: a systematic review. Drugs 71:2031–2065

    PubMed  CAS  Google Scholar 

  • Hess LM, Chambers SK, Hatch K, Hallum A, Janicek MF, Buscema J, Borst M, Johnson C, Slayton L, Chongpison Y et al (2010) Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer. J Support Oncol 8:252–258

    PubMed  Google Scholar 

  • Hobl EL, Mader RM, Erlacher L, Duhm B, Mustak M, Broll H, Hogger P, Kalipciyan M, Jilma B (2011) The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis. Clin Exp Rheumatol 29:963–969

    PubMed  Google Scholar 

  • Horsfield SA, Rosse RB, Tomasino V, Schwartz BL, Mastropaolo J, Deutsch SI (2002) Fluoxetine’s effects on cognitive performance in patients with traumatic brain injury. Int J Psychiatry Med 32:337–344

    PubMed  Google Scholar 

  • Huang GJ, Ben-David E, Tort Piella A, Edwards A, Flint J, Shifman S (2012) Neurogenomic evidence for a shared mechanism of the antidepressant effects of exercise and chronic fluoxetine in mice. PLoS One 7:e35901

    Google Scholar 

  • Huang L, Wong YP, Cai YJ, Lung I, Leung CS, Burd A (2010) Low-dose 5-fluorouracil induces cell cycle G2 arrest and apoptosis in keloid fibroblasts. Br J Dermatol 163:1181–1185

    PubMed  CAS  Google Scholar 

  • Huang WY, Yang PM, Chang YF, Marquez VE, Chen CC (2011) Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2. Biochem Pharmacol 81:510–517

    PubMed  CAS  Google Scholar 

  • Hurria A, Rosen C, Hudis C, Zuckerman E, Panageas KS, Lachs MS, Witmer M, van Gorp WG, Fornier M, D’Andrea G et al (2006) Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J Am Geriatr Soc 54:925–931

    PubMed  Google Scholar 

  • Iconomou G, Koutras A, Karaivazoglou K, Kalliolias GD, Assimakopoulos K, Argyriou AA, Ifanti A, Kalofonos HP (2008) Effect of epoetin alpha therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy. Eur J Cancer Care (Engl) 17:535–541

    CAS  Google Scholar 

  • Imayoshi I, Sakamoto M, Yamaguchi M, Mori K, Kageyama R (2010) Essential roles of Notch signaling in maintenance of neural stem cells in developing and adult brains. J Neurosci 30:3489–3498

    PubMed  CAS  Google Scholar 

  • Inagaki M, Yoshikawa E, Matsuoka Y, Sugawara Y, Nakano T, Akechi T, Wada N, Imoto S, Murakami K, Uchitomi Y (2007) Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 109:146–156

    PubMed  Google Scholar 

  • Inokuchi K (2011) Adult neurogenesis and modulation of neural circuit function. Curr Opin Neurobiol 21:360–364

    PubMed  CAS  Google Scholar 

  • Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR (2011) An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol 38:431–438

    PubMed  Google Scholar 

  • Janelsins MC, Mustian KM, Palesh OG, Mohile SG, Peppone LJ, Sprod LK, Heckler CE, Roscoe JA, Katz AW, Williams JP et al (2012) Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support Care Cancer 20:831–839

    PubMed  Google Scholar 

  • Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA (2011) A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer 19:1647–1656

    PubMed  Google Scholar 

  • Jenkins V, Shilling V, Deutsch G, Bloomfield D, Morris R, Allan S, Bishop H, Hodson N, Mitra S, Sadler G et al (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94:828–834

    PubMed  CAS  Google Scholar 

  • Jenkins V, Shilling V, Fallowfield L, Howell A, Hutton S (2004) Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psychooncology 13:61–66

    PubMed  Google Scholar 

  • Jim HS, Donovan KA, Small BJ, Andrykowski MA, Munster PN, Jacobsen PB (2009) Cognitive functioning in breast cancer survivors: a controlled comparison. Cancer 115:1776–1783

    PubMed  Google Scholar 

  • Jin Y, Lim CM, Kim SW, Park JY, Seo JS, Han PL, Yoon SH, Lee JK (2009) Fluoxetine attenuates kainic acid-induced neuronal cell death in the mouse hippocampus. Brain Res 1281:108–116

    PubMed  CAS  Google Scholar 

  • Joly F, Rigal O, Noal S, Giffard B (2012) Cognitive dysfunction and cancer: which consequences in terms of disease management? Psychooncology 20:1251–1258

    Google Scholar 

  • Joshi G, Aluise CD, Cole MP, Sultana R, Pierce WM, Vore M, St Clair DK, Butterfield DA (2010) Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain. Neuroscience 166:796–807

    Google Scholar 

  • Kendall I, Slotten HA, Codony X, Burgueno J, Pauwels PJ, Vela JM, Fone KC (2011) E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat. Psychopharmacology (Berl) 213:413–430

    CAS  Google Scholar 

  • Kerr IG, Zimm S, Collins JM, O’Neill D, Poplack DG (1984) Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkey. Cancer Res 44:4929–4932

    PubMed  CAS  Google Scholar 

  • Kesler SR, Bennett FC, Mahaffey ML, Spiegel D (2009) Regional brain activation during verbal declarative memory in metastatic breast cancer. Clin Cancer Res 15:6665–6673

    PubMed  CAS  Google Scholar 

  • Kesler SR, Kent JS, O’Hara R (2011) Prefrontal cortex and executive function impairments in primary breast cancer. Arch Neurol 68:1447–1453

    PubMed  Google Scholar 

  • Kochman LJ, Fornal CA, Jacobs BL (2009) Suppression of hippocampal cell proliferation by short-term stimulant drug administration in adult rats. Eur J Neurosci 29:2157–2165

    PubMed  Google Scholar 

  • Kodama M, Fujioka T, Duman RS (2004) Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol Psychiatry 56:570–580

    PubMed  CAS  Google Scholar 

  • Koehl M, Abrous DN (2011) A new chapter in the field of memory: adult hippocampal neurogenesis. Eur J Neurosci 33:1101–1114

    PubMed  Google Scholar 

  • Kohli S, Fisher SG, Tra Y, Adams MJ, Mapstone ME, Wesnes KA, Roscoe JA, Morrow GR (2009) The effect of modafinil on cognitive function in breast cancer survivors. Cancer 115:2605–2616

    PubMed  CAS  Google Scholar 

  • Konat GW, Kraszpulski M, James I, Zhang HT, Abraham J (2008) Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats. Metab Brain Dis 23:325–333

    PubMed  CAS  Google Scholar 

  • Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Gundy C, Schagen SB (2012) Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol 30:1080–1086

    PubMed  Google Scholar 

  • Koppelmans V, de Ruiter MB, van der Lijn F, Boogerd W, Seynaeve C, van der Lugt A, Vrooman H, Niessen WJ, Breteler MM, Schagen SB (2012). Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Res Treat 132:1099–1106

    Google Scholar 

  • Kotani S, Yamauchi T, Teramoto T, Ogura H (2008) Donepezil, an acetylcholinesterase inhibitor, enhances adult hippocampal neurogenesis. Chem Biol Interact 175:227–230

    PubMed  CAS  Google Scholar 

  • Kreukels BP, Hamburger HL, de Ruiter MB, van Dam FS, Ridderinkhof KR, Boogerd W, Schagen SB (2008a) ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy. Clin Neurophysiol 119:533–541

    PubMed  Google Scholar 

  • Kreukels BP, van Dam FS, Ridderinkhof KR, Boogerd W, Schagen SB (2008b) Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer. Clin Breast Cancer 8:80–87

    PubMed  CAS  Google Scholar 

  • Kurita K, Meyerowitz BE, Hall P, Gatz M (2011) Long-term cognitive impairment in older adult twins discordant for gynecologic cancer treatment. J Gerontol A Biol Sci Med Sci 66:1343–1349

    PubMed  Google Scholar 

  • Lerner C, Harrison DE (1990) 5-Fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp Hematol 18:114–118

    PubMed  CAS  Google Scholar 

  • Li CQ, Liu D, Huang L, Wang H, Zhang JY, Luo XG (2008) Cytosine arabinoside treatment impairs the remote spatial memory function and induces dendritic retraction in the anterior cingulate cortex of rats. Brain Res Bull 77:237–240

    PubMed  CAS  Google Scholar 

  • Li Y, Vijayanathan V, Gulinello M, Cole PD (2010a) Intrathecal methotrexate induces focal cognitive deficits and increases cerebrospinal fluid homocysteine. Pharmacol Biochem Behav 95:428–433

    PubMed  CAS  Google Scholar 

  • Li Y, Vijayanathan V, Gulinello ME, Cole PD (2010b) Systemic methotrexate induces spatial memory deficits and depletes cerebrospinal fluid folate in rats. Pharmacol Biochem Behav 94:454–463

    PubMed  CAS  Google Scholar 

  • Lim CM, Kim SW, Park JY, Kim C, Yoon SH, Lee JK (2009) Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect. J Neurosci Res 87:1037–1045

    PubMed  CAS  Google Scholar 

  • Lombardero M, Kovacs K, Scheithauer BW (2011) Erythropoietin: a hormone with multiple functions. Pathobiology 78:41–53

    PubMed  CAS  Google Scholar 

  • Long JM, Lee GD, Kelley-Bell B, Spangler EL, Perez EJ, Longo DL, de Cabo R, Zou S, Rapp PR (2011) Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats. Pharmacol Biochem Behav 100:205–211

    Google Scholar 

  • Lower EE, Fleishman S, Cooper A, Zeldis J, Faleck H, Yu Z, Manning D (2009) Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. J Pain Symptom Manage 38:650–662

    PubMed  CAS  Google Scholar 

  • Lugert S, Basak O, Knuckles P, Haussler U, Fabel K, Gotz M, Haas CA, Kempermann G, Taylor V, Giachino C (2010) Quiescent and active hippocampal neural stem cells with distinct morphologies respond selectively to physiological and pathological stimuli and aging. Cell Stem Cell 6:445–456

    PubMed  CAS  Google Scholar 

  • Lundorff LE, Jonsson BH, Sjogren P (2009) Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial. Palliat Med 23:731–738

    PubMed  CAS  Google Scholar 

  • Lyons L, Bennett G, Wigmore P (2011a). Animal models of cognitive impairment induced by methotrexate. In: Castillo V, Moyano L (eds) Methotrexate: pharmacology, clinical uses and adverse effects. Nova Science Publishers, Hauppauge

    Google Scholar 

  • Lyons L, Elbeltagy M, Bennett G, Wigmore P (2011b) The effect of cyclophosphamide on hippocampal cell proliferation and spatial working memory in the rat. PlosOne 6:e21445

    CAS  Google Scholar 

  • Lyons L, ElBeltagy M, Bennett G, Wigmore P (2012) Fluoxetine counteracts the cognitive and cellular effects of 5-fluorouracil in the rat hippocampus by a mechanism of prevention rather than recovery. PLoS One 7:e30010

    PubMed  CAS  Google Scholar 

  • Lyons L, Elbeltagy M, Umka J, Markwick R, Startin C, Bennett G, Wigmore P (2011c) Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by mehtotrexate chemotherapy. Psychopharmacology 215:105–115

    PubMed  CAS  Google Scholar 

  • Maccormick RE (2006) Possible acceleration of aging by adjuvant chemotherapy: a cause of early onset frailty? Med Hypotheses 67:212–215

    PubMed  CAS  Google Scholar 

  • Macleod JE, DeLeo JA, Hickey WF, Ahles TA, Saykin AJ, Bucci DJ (2007) Cancer chemotherapy impairs contextual but not cue-specific fear memory. Behav Brain Res 181:168–172

    PubMed  CAS  Google Scholar 

  • Mancuso A, Migliorino M, De Santis S, Saponiero A, De Marinis F (2006) Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Ann Oncol 17:146–150

    PubMed  CAS  Google Scholar 

  • Mar Fan HG, Clemons M, Xu W, Chemerynsky I, Breunis H, Braganza S, Tannock IF (2008) A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer 16:577–583

    PubMed  Google Scholar 

  • Mar Fan HG, Houede-Tchen N, Yi QL, Chemerynsky I, Downie FP, Sabate K, Tannock IF (2005) Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 23:8025–8032

    Google Scholar 

  • Marcussen AB, Flagstad P, Kristjansen PE, Johansen FF, Englund U (2008) Increase in neurogenesis and behavioural benefit after chronic fluoxetine treatment in Wistar rats. Acta Neurol Scand 117:94–100

    PubMed  CAS  Google Scholar 

  • Marin-Burgin A, Schinder AF (2012) Requirement of adult-born neurons for hippocampus-dependent learning. Behav Brain Res 227:391–399

    PubMed  Google Scholar 

  • Massa E, Madeddu C, Lusso MR, Gramignano G, Mantovani G (2006) Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy. Crit Rev Oncol Hematol 57:175–182

    PubMed  Google Scholar 

  • McDonald BC, Conroy SK, Ahles TA, West JD, Saykin AJ (2010) Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat 123:819–828

    PubMed  CAS  Google Scholar 

  • McDonald BC, Conroy SK, Ahles TA, West JD, Saykin AJ (2012) Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J Clin Oncol 30:2500–2508

    PubMed  Google Scholar 

  • Mehlsen M, Pedersen AD, Jensen AB, Zachariae R (2008) No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psychooncology 18:248–257

    Google Scholar 

  • Merzoug S, Toumi ML, Boukhris N, Baudin B, Tahraoui A (2011) Adriamycin-related anxiety-like behavior, brain oxidative stress and myelotoxicity in male Wistar rats. Pharmacol Biochem Behav 99:639–647

    PubMed  CAS  Google Scholar 

  • Meunier J, Ieni J, Maurice T (2006) The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor. Br J Pharmacol 149:998–1012

    PubMed  CAS  Google Scholar 

  • Ming GL, Song H (2011) Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron 70:687–702

    PubMed  CAS  Google Scholar 

  • Minzenberg MJ, Carter CS (2008) Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology 33:1477–1502

    PubMed  CAS  Google Scholar 

  • Miskowiak K, O’Sullivan U, Harmer CJ (2007) Erythropoietin enhances hippocampal response during memory retrieval in humans. J Neurosci 27:2788–2792

    PubMed  CAS  Google Scholar 

  • Mitchell T, Turton P (2011) ‘Chemobrain’: concentration and memory effects in people receiving chemotherapy—a descriptive phenomenological study. Eur J Cancer Care (Engl) 20:539–548

    CAS  Google Scholar 

  • Mohamed Ariff I, Mitra A, Basu A (2012) Epigenetic regulation of self-renewal and fate determination in neural stem cells. J Neurosci Res 90:529–539

    PubMed  CAS  Google Scholar 

  • Mondie CM, Vandergrift KA, Wilson CL, Gulinello ME, Weber ET (2010) The chemotherapy agent, thioTEPA, yields long-term impairment of hippocampal cell proliferation and memory deficits but not depression-related behaviors in mice. Behav Brain Res 209:66–72

    PubMed  CAS  Google Scholar 

  • Monje M, Dietrich J (2012) Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis. Behav Brain Res 227:376–379

    Google Scholar 

  • Mowla A, Mosavinasab M, Pani A (2007) Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial. J Clin Psychopharmacol 27:67–70

    PubMed  CAS  Google Scholar 

  • Mustafa S, Walker A, Bennett G, Wigmore PM (2008) 5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus. Eur J Neurosci 28:323–330

    PubMed  Google Scholar 

  • Myers JS (2010) The possible role of cytokines in chemotherapy-induced cognitive deficits. Adv Exp Med Biol 678:119–123

    PubMed  CAS  Google Scholar 

  • Myers JS (2012) Chemotherapy-related cognitive impairment: the breast cancer experience. Oncol Nurs Forum 39:E31–E40

    PubMed  Google Scholar 

  • O’Leary OF, Wu X, Castren E (2009) Chronic fluoxetine treatment increases expression of synaptic proteins in the hippocampus of the ovariectomized rat: role of BDNF signalling. Psychoneuroendocrinology 34:367–381

    PubMed  Google Scholar 

  • O’Shaughnessy JA, Vukelja SJ, Holmes FA, Savin M, Jones M, Royall D, George M, Von Hoff D (2005) Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy. Clin Breast Cancer 5:439–446

    PubMed  Google Scholar 

  • Oster HS, Neumann D, Hoffman M, Mittelman M (2012) Erythropoietin: the swinging pendulum. Leuk Res 36:939–944

    PubMed  CAS  Google Scholar 

  • Paganini-Hill A, Clark LJ (2000) Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 64:165–176

    PubMed  CAS  Google Scholar 

  • Palmer TD, Willhoite AR, Gage FH (2000) Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 425:479–494

    PubMed  CAS  Google Scholar 

  • Pechnick RN, Zonis S, Wawrowsky K, Cosgayon R, Farrokhi C, Lacayo L, Chesnokova V (2011) Antidepressants stimulate hippocampal neurogenesis by inhibiting p21 expression in the subgranular zone of the hipppocampus. PLoS One 6:e27290

    PubMed  CAS  Google Scholar 

  • Phillips KM, Jim HS, Small BJ, Laronga C, Andrykowski MA, Jacobsen PB (2011) Cognitive functioning after cancer treatment: a 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls. Cancer 118:1925–1932

    PubMed  Google Scholar 

  • Ponce LL, Navarro JC, Ahmed O, Robertson CS (2012) Erythropoietin neuroprotection with traumatic brain injury. Pathophysiology (Epub ahead of print)

    Google Scholar 

  • Potrata B, Cavet J, Blair S, Howe T, Molassiotis A (2010) ‘Like a sieve’: an exploratory study on cognitive impairments in patients with multiple myeloma. Eur J Cancer Care (Engl) 19:721–728

    CAS  Google Scholar 

  • Pusztai L, Mendoza TR, Reuben JM, Martinez MM, Willey JS, Lara J, Syed A, Fritsche HA, Bruera E, Booser D et al (2004) Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine 25:94–102

    PubMed  CAS  Google Scholar 

  • Pyter LM, Cochrane SF, Ouwenga RL, Patel PN, Pineros V, Prendergast BJ (2010) Mammary tumors induce select cognitive impairments. Brain Behav Immun 24:903–907

    PubMed  Google Scholar 

  • Pyter LM, Pineros V, Galang JA, McClintock MK, Prendergast BJ (2009) Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation. Proc Natl Acad Sci USA 106:9069–9074

    PubMed  CAS  Google Scholar 

  • Quesnel C, Savard J, Ivers H (2009) Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat 116:113–123

    PubMed  Google Scholar 

  • Randall TD, Weissman IL (1997) Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood 89:3596–3606

    PubMed  CAS  Google Scholar 

  • Ransome MI, Turnley AM (2007) Systemically delivered erythropoietin transiently enhances adult hippocampal neurogenesis. J Neurochem 102:1953–1965

    PubMed  CAS  Google Scholar 

  • Rebbaa A, Zheng X, Chu F, Mirkin BL (2006) The role of histone acetylation versus DNA damage in drug-induced senescence and apoptosis. Cell Death Differ 13:1960–1967

    PubMed  CAS  Google Scholar 

  • Reid-Arndt SA, Hsieh C, Perry MC (2010) Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer. Psychooncology 19:535–544

    PubMed  Google Scholar 

  • Repantis D, Schlattmann P, Laisney O, Heuser I (2010) Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res 62:187–206

    PubMed  CAS  Google Scholar 

  • Riquelme PA, Drapeau E, Doetsch F (2008) Brain micro-ecologies: neural stem cell niches in the adult mammalian brain. Philos Trans R Soc Lond B Biol Sci 363:123–137

    PubMed  Google Scholar 

  • Roscoe JA, Morrow GR, Hickok JT, Mustian KM, Griggs JJ, Matteson SE, Bushunow P, Qazi R, Smith B (2005) Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 89:243–249

    PubMed  CAS  Google Scholar 

  • Rzeski W, Pruskil S, Macke A, Felderhoff-Mueser U, Reiher AK, Hoerster F, Jansma C, Jarosz B, Stefovska V, Bittigau P et al (2004) Anticancer agents are potent neurotoxins in vitro and in vivo. Ann Neurol 56:351–360

    PubMed  CAS  Google Scholar 

  • Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, van Dam FS (2006) Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 98:1742–1745

    PubMed  CAS  Google Scholar 

  • Schagen SB, Muller MJ, Boogerd W, Rosenbrand RM, van Rhijn D, Rodenhuis S, van Dam FS (2002) Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol 13:1387–1397

    PubMed  CAS  Google Scholar 

  • Schanzer A, Wachs FP, Wilhelm D, Acker T, Cooper-Kuhn C, Beck H, Winkler J, Aigner L, Plate KH, Kuhn HG (2004) Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol 14:237–248

    PubMed  Google Scholar 

  • Scherling C, Collins B, Mackenzie J, Bielajew C, Smith A (2012a) Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: an FMRI study. Front Hum Neurosci 5:122

    Google Scholar 

  • Scherling C, Collins B, Mackenzie J, Bielajew C, Smith A (2012b) Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: a functional magnetic resonance imaging study. J Clin Exp Neuropsychol 34:543–560

    Google Scholar 

  • Scherwath A, Mehnert A, Schleimer B, Schirmer L, Fehlauer F, Kreienberg R, Metzner B, Thiel E, Zander AR, Schulz-Kindermann F et al (2006) Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects. Ann Oncol 17:415–423

    PubMed  CAS  Google Scholar 

  • Schilder CM, Seynaeve C, Beex LV, Boogerd W, Linn SC, Gundy CM, Huizenga HM, Nortier JW, van de Velde CJ, van Dam FS et al (2010) Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. J Clin Oncol 28:1294–1300

    PubMed  CAS  Google Scholar 

  • Seigers R, Fardell JE (2011) Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research. Neurosci Biobehav Rev 35:729–741

    PubMed  Google Scholar 

  • Seigers R, Schagen SB, Coppens CM, van der Most PJ, van Dam FS, Koolhaas JM, Buwalda B (2009) Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats. Behav Brain Res 201:279–284

    PubMed  CAS  Google Scholar 

  • Seigers R, Pourtau L, Schagen SB, van Dam FS, Koolhaas JM, Konsman JP, Buwalda B (2010a) Inhibition of hippocampal cell proliferation by methotrexate in rats is not potentiated by the presence of a tumor. Brain Res Bull 81:472–476

    PubMed  CAS  Google Scholar 

  • Seigers R, Timmermans J, van der Horn HJ, de Vries EF, Dierckx RA, Visser L, Schagen SB, van Dam FS, Koolhaas JM, Buwalda B (2010b) Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release. Behav Brain Res 207:265–272

    PubMed  CAS  Google Scholar 

  • Sharpe MJ, Fardell JE, Vardy J, Johnston IN (2012) The chemotherapy agent oxaliplatin impairs the renewal of fear to an extinguished conditioned stimulus in rats. Behav Brain Res 227:295–299

    PubMed  CAS  Google Scholar 

  • Shaw EG, Rosdhal R, D’Agostino RB, Jr Lovato J, Naughton MJ, Robbins ME, Rapp SR (2006). Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol 24:1415–1420

    Google Scholar 

  • Shen Q, Goderie SK, Jin L, Karanth N, Sun Y, Abramova N, Vincent P, Pumiglia K, Temple S (2004) Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304:1338–1340

    PubMed  CAS  Google Scholar 

  • Silverman DH, Dy CJ, Castellon SA, Lai J, Pio BS, Abraham L, Waddell K, Petersen L, Phelps ME, Ganz PA (2007) Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy. Breast Cancer Res Treat 103:303–311

    PubMed  CAS  Google Scholar 

  • Small BJ, Rawson KS, Walsh E, Jim HS, Hughes TF, Iser L, Andrykowski MA, Jacobsen PB (2011) Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors. Cancer 117:1369–1376

    PubMed  CAS  Google Scholar 

  • Steffener J, Stern Y (2012) Exploring the neural basis of cognitive reserve in aging. Biochim Biophys Acta 1822:467–473

    PubMed  CAS  Google Scholar 

  • Subiros N, Del Barco DG, Coro-Antich RM (2012) Erythropoietin: still on the neuroprotection road. Ther Adv Neurol Disord 5:161–173

    PubMed  CAS  Google Scholar 

  • Sun J, Ming GL, Song H (2011) Epigenetic regulation of neurogenesis in the adult mammalian brain. Eur J Neurosci 33:1087–1093

    PubMed  Google Scholar 

  • Tager FA, McKinley PS, Schnabel FR, El-Tamer M, Cheung YK, Fang Y, Golden CR, Frosch ME, Habif U, Mulligan MM et al (2010) The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Breast Cancer Res Treat 123:25–34

    PubMed  Google Scholar 

  • Tangpong J, Cole MP, Sultana R, Joshi G, Estus S, Vore M, St Clair W, Ratanachaiyavong S, St Clair DK, Butterfield DA (2006) Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity. Neurobiol Dis 23:127–139

    Google Scholar 

  • Tchen N, Juffs HG, Downie FP, Yi QL, Hu H, Chemerynsky I, Clemons M, Crump M, Goss PE, Warr D et al (2003) Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21:4175–4183

    PubMed  Google Scholar 

  • Tsavaris N, Kosmas C, Vadiaka M, Kanelopoulos P, Boulamatsis D (2002) Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br J Cancer 87:21–27

    PubMed  CAS  Google Scholar 

  • Umka J, Mustafa S, Elbeltagy M, Thorpe A, Latif L, Bennett G, Wigmore PM (2010) Valproic acid reduces spatial working memory and cell proliferation in the hippocampus. Neuroscience 166:15–22

    PubMed  CAS  Google Scholar 

  • van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, Rodenhuis S (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210–218

    Google Scholar 

  • van Praag H, Shubert T, Zhao C, Gage FH (2005) Exercise enhances learning and hippocampal neurogenesis in aged mice. J Neurosci 25:8680–8685

    PubMed  Google Scholar 

  • Vearncombe KJ, Rolfe M, Andrew B, Pachana NA, Wright M, Beadle G (2011) Cognitive effects of chemotherapy-induced menopause in breast cancer. Clin Neuropsychol 25:1295–1313

    PubMed  Google Scholar 

  • Vearncombe KJ, Rolfe M, Wright M, Pachana NA, Andrew B, Beadle G (2009) Predictors of cognitive decline after chemotherapy in breast cancer patients. J Int Neuropsychol Soc 15:951–962

    PubMed  Google Scholar 

  • Volz TJ (2008) Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate. Curr Neuropharmacol 6:379–385

    PubMed  CAS  Google Scholar 

  • von Bohlen und Halbach O (2011) Immunohistological markers for proliferative events, gliogenesis, and neurogenesis within the adult hippocampus. Cell Tissue Res 345:1–19

    Google Scholar 

  • Walker EA, Foley JJ, Clark-Vetri R, Raffa RB (2011) Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice. Psychopharmacology (Berl) 217:539–548

    CAS  Google Scholar 

  • Wang Y, Probin V, Zhou D (2006) Cancer therapy-induced residual bone marrow injury-Mechanisms of induction and implication for therapy. Curr Cancer Ther Rev 2:271–279

    PubMed  CAS  Google Scholar 

  • Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100:2292–2299

    PubMed  CAS  Google Scholar 

  • Wefel JS, Saleeba AK, Buzdar AU, Meyers CA (2010) Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116:3348–3356

    PubMed  Google Scholar 

  • Wefel JS, Vardy J, Ahles T, Schagen SB (2011) International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12:703–708

    PubMed  Google Scholar 

  • Weis J, Poppelreuter M, Bartsch HH (2009) Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: ‘subjective’ complaints and ‘objective’ neuropsychological test results. Psychooncology 18:775–782

    PubMed  CAS  Google Scholar 

  • Whitney KA, Lysaker PH, Steiner AR, Hook JN, Estes DD, Hanna NH (2008) Is “chemobrain” a transient state? A prospective pilot study among persons with non-small cell lung cancer. J Support Oncol 6:313–321

    PubMed  Google Scholar 

  • Wick A, Wick W, Hirrlinger J, Gerhardt E, Dringen R, Dichgans J, Weller M, Schulz JB (2004) Chemotherapy-induced cell death in primary cerebellar granule neurons but not in astrocytes: in vitro paradigm of differential neurotoxicity. J Neurochem 91:1067–1074

    PubMed  CAS  Google Scholar 

  • Wieneke MH, Dienst ER (1995) Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-oncology 4:61–66

    Google Scholar 

  • Wigmore PM, Mustafa S, El-Beltagy M, Lyons L, Umka J, Bennett G (2010) Effects of 5-FU. Adv Exp Med Biol 678:157–164

    PubMed  CAS  Google Scholar 

  • Wilson CL, Weber ET (2013) Chemotherapy drug thioTEPA exacerbates stress-induced anhedonia and corticosteroid responses but not impairment of hippocampal cell proliferation in adult mice. Behav Brain Res 236C:180–185

    Google Scholar 

  • Winocur G, Binns MA, Tannock I (2011) Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model. Neuropharmacology 61:1222–1228

    PubMed  CAS  Google Scholar 

  • Winocur G, Henkelman M, Wojtowicz JM, Zhang H, Binns MA, Tannock IF (2012) The effects of chemotherapy on cognitive function in a mouse model: a prospective study. Clin Cancer Res 18:3112–3121

    PubMed  CAS  Google Scholar 

  • Wong-Goodrich SJ, Pfau ML, Flores CT, Fraser JA, Williams CL, Jones LW (2010) Voluntary running prevents progressive memory decline and increases adult hippocampal neurogenesis and growth factor expression after whole-brain irradiation. Cancer Res 70:9329–9338

    PubMed  CAS  Google Scholar 

  • Wu MD, Hein AM, Moravan MJ, Shaftel SS, Olschowka JA, O’Banion MK (2012) Adult murine hippocampal neurogenesis is inhibited by sustained IL-1beta and not rescued by voluntary running. Brain Behav Immun 26:292–300

    PubMed  CAS  Google Scholar 

  • Yamada TH, Denburg NL, Beglinger LJ, Schultz SK (2010) Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy. J Neuropsychiatry Clin Neurosci 22:48–54

    PubMed  Google Scholar 

  • Yang M, Kim JS, Kim J, Jang S, Kim SH, Kim JC, Shin T, Wang H, Moon C (2012) Acute treatment with methotrexate induces hippocampal dysfunction in a mouse model of breast cancer. Brain Res Bull 89:50–56

    PubMed  CAS  Google Scholar 

  • Yang M, Kim JS, Kim J, Kim SH, Kim JC, Wang H, Shin T, Moon C (2011) Neurotoxicity of methotrexate to hippocampal cells in vivo and in vitro. Biochem Pharmacol 82:72–80

    PubMed  CAS  Google Scholar 

  • Yang M, Kim JS, Song MS, Kim SH, Kang SS, Bae CS, Kim JC, Wang H, Shin T, Moon C (2010) Cyclophosphamide impairs hippocampus-dependent learning and memory in adult mice: possible involvement of hippocampal neurogenesis in chemotherapy-induced memory deficits. Neurobiol Learn Mem 93:487–494

    PubMed  CAS  Google Scholar 

  • Yoshikawa E, Matsuoka Y, Inagaki M, Nakano T, Akechi T, Kobayakawa M, Fujimori M, Nakaya N, Akizuki N, Imoto S et al (2005) No adverse effects of adjuvant chemotherapy on hippocampal volume in Japanese breast cancer survivors. Breast Cancer Res Treat 92:81–84

    PubMed  Google Scholar 

  • Yoshiyama Y, Kojima A, Ishikawa C, Arai K (2010) Anti-inflammatory action of donepezil ameliorates tau pathology, synaptic loss, and neurodegeneration in a tauopathy mouse model. J Alzheimers Dis 22:295–306

    PubMed  CAS  Google Scholar 

  • Zhang L, Plotkin RC, Wang G, Sandel ME, Lee S (2004) Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. Arch Phys Med Rehabil 85:1050–1055

    PubMed  Google Scholar 

  • Zhang Y, Gao Y, Zhang G, Huang S, Dong Z, Kong C, Su D, Du J, Zhu S, Liang Q et al (2011) DNMT3a plays a role in switches between doxorubicin-induced senescence and apoptosis of colorectal cancer cells. Int J Cancer 128:551–561

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Biomedical Sciences, Queen’s Medical Centre, Nottingham, NG7 2UH, UK

    Peter Wigmore

Authors
  1. Peter Wigmore
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Wigmore .

Editor information

Editors and Affiliations

  1. , INSERM 930, Faculté des Sciences, Parc Grandmont, Tours, 37200, France

    Catherine Belzung

  2. Medical School, Queen's Medical Centre, University of Nottingham, Nottingham, NG7 2UH, United Kingdom

    Peter Wigmore

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Wigmore, P. (2012). The Effect of Systemic Chemotherapy on Neurogenesis, Plasticity and Memory. In: Belzung, C., Wigmore, P. (eds) Neurogenesis and Neural Plasticity. Current Topics in Behavioral Neurosciences, vol 15. Springer, Berlin, Heidelberg. https://doi.org/10.1007/7854_2012_235

Download citation

Publish with us

Policies and ethics

Search

Navigation